Proteasome inhibition in hypertrophied myocardium

Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1373-4. doi: 10.1152/ajpheart.00886.2008. Epub 2008 Aug 15.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cardiomegaly / complications
  • Cardiomegaly / drug therapy*
  • Cardiomegaly / enzymology
  • Cardiomegaly / physiopathology
  • Collagen / metabolism
  • Disease Models, Animal
  • Heart Failure / enzymology
  • Heart Failure / etiology
  • Heart Failure / physiopathology
  • Heart Failure / prevention & control
  • Humans
  • Myocardium / enzymology*
  • Myocardium / pathology
  • NF-kappa B / metabolism
  • Oligopeptides / pharmacology
  • Protease Inhibitors / pharmacology*
  • Proteasome Endopeptidase Complex / metabolism
  • Proteasome Inhibitors*
  • Ventricular Function, Left / drug effects
  • Ventricular Remodeling / drug effects*

Substances

  • NF-kappa B
  • Oligopeptides
  • Protease Inhibitors
  • Proteasome Inhibitors
  • Collagen
  • Proteasome Endopeptidase Complex
  • epoxomicin